Allarity Therapeutics share price logo

Allarity Therapeutics

NASDAQ: ALLR

$0.86

+0.01

(+1.31%)

Live

as on

Allarity Therapeutics Stock Performance

as on October 24, 2026 at 6:20 am IST

  • Day's Low

    Day's High

    $0.84
    $0.90
    downward going graph

    2.06%

    Downside

    4.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.77
    $1.84
    downward going graph

    10.38%

    Downside

    114.47%

    Upside

    downward going graph

Allarity Therapeutics share price movements today

Previous Close
$0.85
Open
$0.85
Volume
683.9K
Market Cap
$14.0M
Day's Low - High
$0.84 - $0.90
52 Week Low - High
$0.77 - $1.84

Allarity Therapeutics Historical Returns

1 Month Return
-18.6 %
3 Month Return
-30.61 %
1 Year Return
-39.09 %
3 Year Return
-99.78 %
5 Year Return
0 %

Allarity Therapeutics Stock Fundamentals & Key Indicators

Check Allarity Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.0M

EPS (TTM)

-0.78

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.13

Industry PE ratio

-3.14

PEG Ratio

-0.01

EBITDA

-11.1M

Revenue (TTM)

345.0K

Profit Margin

107.54%

Return On Equity TTM

-152.77%

Allarity Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Allarity Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$14.0MNA-1.13107.54%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Allarity Therapeutics Stock including INR - Dollar returns

The Allarity Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Allarity Therapeutics investment value today

Current value as on today

₹66,739

Returns

-₹33,261

(-33.26%)

Returns from Allarity Therapeutics Stock

-₹38,295 (-38.29%)

Dollar Impact

₹5,034 (+5.03%)

Analyst Recommendation on Allarity Therapeutics Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Allarity Therapeutics. Average target price of $11

Allarity Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Allarity Therapeutics.

What analysts predicted

92.2%UPSIDE

Target Price

$11

Current Price

$0.8577

Analyzed by

6 Analysts

Target

$11.00

Allarity Therapeutics target price $11, a slight upside of 92.2% compared to current price of $0.8577. According to 6 analysts rating.

Indian Investors' Interest in Allarity Therapeutics Stock

Search interest for Allarity Therapeutics Stock has increased by 429% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:429% versus previous 30 day period

Allarity Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
0
-
Gross Profit
-
-
-
0
-
-
-
-
0
-
Operating Income
-4
-4
-4
-3
-12
-3
-4
-2
-2
-2
EBITDA
-4
-1
-3
-1
-11
-2
-2
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-1
-3
-1
-11
-2
-2
-2
-2
-3
Income Tax Expense
-
0
0
-
0
-
-
-
-
-
Net Income
-4
-1
-3
-1
-11
-2
-2
-2
-2
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
204.00%
0.00%

Allarity Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Total Revenue
0
-
-
-
-
-
0
Gross Profit
0
-
0
0
0
-
0
Operating Income
-17
-8
-26
-34
-17
-27
-12
EBITDA
-15
-6
-25
-17
-11
-24
-11
Interest Expense
3
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-18
-6
-26
-17
-11
-24
-11
Income Tax Expense
-4
0
0
-1
0
0
-
Net Income
-14
-6
-26
-16
-11
-24
-11
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%

Allarity Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-4
-1
-3
-1
-11
-2
-2
-2
-2
-3
Operating Cash Flow
-5
-1
-1
-7
-5
-2
-5
-3
-4
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
0
-
Financing Cash Flow
6
0
1
26
4
11
-2
2
19
-
Change in Cash
0
-1
0
18
0
8
-9
0
15
-2

Allarity Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Net Income
-4
-2
-14
-5
-26
-16
-11
-24
-11
Operating Cash Flow
-1
-4
-10
-7
-15
-16
-12
-17
-14
Investing Cash Flow
0
1
0
0
1
0
-
0
0
Financing Cash Flow
1
2
11
6
33
-1
10
36
10
Change in Cash
-1
0
1
-1
19
-17
-1
19
-4

Global Institutional Holdings in Allarity Therapeutics

Check out the Institutions with significant holdings in Allarity Therapeutics.

Funds
Holdings
VANGUARD INDEX FUNDS
1.08%
Vanguard
1.08%
Fidelity Concord Street Trust
0.82%

Allarity Therapeutics News & Key Events

  • img

    Today's Timeline - 27 April

    Mon, 05:32 PM

    -

    Allarity Therapeutics announces Notice of Allowance for stenoparib DRP® test patent from the US Patent and Trademark Office.

Insights on Allarity Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 711.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 257.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ALLR stock has moved down by -99.8%

About Allarity Therapeutics

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The company's portfolio of investigational drugs for various cancers includes: Stenoparib: A poly-ADP-ribose polymerase (PARP) inhibitor currently in Phase 2 clinical trials for ovarian cancer. Dovitinib: A pan-tyrosine kinase inhibitor designed to treat renal cell carcinoma. IXEMPRA: A microtubule inhibitor used in the treatment of metastatic breast cancer. LiPlaCis: A liposomal formulation of cisplatin, undergoing Phase 2 clinical trials for metastatic breast cancer. 2X-111: A liposomal formulation of doxorubicin, also in Phase 2 studies for both metastatic breast cancer and glioblastoma multiforme. Established in 2004, Allarity Therapeutics maintains its headquarters in Cambridge, Massachusetts.
OrganisationAllarity Therapeutics
Headquarters123 E. Tarpon Ave., Tarpon Springs, FL, 34689, US
IndustryBiotechnology
CEOThomas H. Jensen

Key Management of Allarity Therapeutics

Name

Title

Mr. Thomas H. Jensen

Founder, CEO & Director

Dr. Jeremy R. Graff Ph.D.

President & Chief Development Officer

Dr. Steen Meier Knudsen Ph.D.

Founder & Chief Scientific Officer

Mr. Jeffrey S. Ervin M.B.A.

Chief Financial Officer

Dr. Jose L. Iglesias M.D.

Consultant Chief Medical Officer

FAQs

What is Allarity Therapeutics share price today?

Allarity Therapeutics share price today is $0.86 as on . Allarity Therapeutics share today touched a day high of $0.90 and a low of $0.84.

What is the 52 week high and 52 week low for Allarity Therapeutics share?

Allarity Therapeutics share touched a 52 week high of $1.84 on and a 52 week low of $0.77 on . Allarity Therapeutics stock price today i.e. is trending at $0.86,which is 53.37% down from its 52 week high and 11.58% up from its 52 week low.

What is Allarity Therapeutics's market capitalisation today?

Allarity Therapeutics market capitalisation is $0.00T as on .

How to invest in Allarity Therapeutics Stock (ALLR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Allarity Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Allarity Therapeutics Stock (ALLR) from India?

Indian investors can start investing in Allarity Therapeutics (ALLR) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Allarity Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Allarity Therapeutics share’s latest price of $0.86 as on October 24, 2026 at 12:50 am IST, you will get 11.6591 shares of Allarity Therapeutics. Learn more about fractional shares .